Review
The use and resistance to antibiotics in the community

https://doi.org/10.1016/S0924-8579(02)00394-1Get rights and content

Abstract

The frequency of resistance to antibiotics among common community-acquired pathogens, and the number of drugs to which they are resistant have been increasing worldwide. The relationship between antibiotic usage and resistance is strongly supported by data from several studies. Countries with the highest per capita antibiotic consumption have the highest resistance. The emergence of penicillin-resistant Streptococcus pneumoniae is related to high consumption of antibiotics in general, as well as to increased use of aminopenicillins and/or probably to wider use of oral cephalosporins. Increased consumption of macrolides, especially the long-acting ones, correlates significantly with the level of macrolide resistance of group A streptococci and S. pneumoniae while increased use of oral cephalosporins might be associated with the increase of β-lactamase-producing strains of Moraxella catarrhalis. Trimethoprim/sulphamethoxazole resistance is strongly associated with resistance to penicillin. A rise in consumption of fluoroquinolones is consonant with a higher rate of resistance to quinolones of S. pneumoniae, Escherichia coli and other Gram-negative bacteria. Paediatric bacterial isolates are more often resistant to various antimicrobial agents than isolates from adult patients; this higher resistance rate may be due to more frequent antimicrobial treatments in children, and extensive child to child transmission. Reliable data on antimicrobial consumption and resistance should form a basis for national policies devised to reduce the resistance of microorganisms to antibiotics.

Introduction

Antibiotics are given to humans and animals for therapy and prophylaxis of infectious diseases. They are also used in animals for growth promotion and, to a lesser extent, in agriculture for plant protection and in industry [1]. In humans, 80–90% of antimicrobial drugs are used in outpatients and the rest in the hospitals [1], [2], [3], [4]. It is estimated that 20–50% of all antibiotic use is questionable [1]. The consequences of antibiotic overuse and misuse include increased risk of adverse side effects, higher cost and higher rate of antimicrobial resistance of community pathogens. What distinguishes antimicrobial agents from other drugs, is that each antimicrobial agent used may have potential significant effect on, the world microbial ecology. Antibiotics affect both pathogens and the normal flora. In theory any antibiotic can select resistant strains as long as the local concentration of the drug exceeds the minimal inhibitory concentration (MIC) for the susceptible bacterial population but is below the MIC for the resistant clone. To what extent disturbances occur depends on the spectrum of the agent, dose, route of administration, pharmacokinetic and pharmacodynamic properties, and in vivo inactivation of the agent [5]. Incomplete absorption of orally administered drugs may influence the intestinal microflora, and secretion of an antimicrobial agent by the intestinal or vaginal mucosa, bile, salivary glands or eccrine or apocrine sweat glands may interfere with the normal flora at different habitats. As a consequence, antibiotic-resistant microorganisms may increase in numbers, and they also might serve as reservoirs for resistance genes. One antibiotic may select for resistance to one or more structurally unrelated antibiotics, because resistance may be genetically linked (via co-selection of multi-resistance plasmids and other resistance traits) [6]. Some antimicrobial agents are more selective for resistance than others [7]. Besides selective antibiotic pressure, transferable resistance (clonal spread or horizontal resistance gene transfer) is the major determinant of resistance development [8]. There are several ways to study the relationship between antibiotic usage and the incidence of bacterial resistance. Pharmacoepidemiology, mathematical modelling, pharmacokinetic and microbiological analysis of several body sites that normally harbour dense microbial flora are the methods used to study the evaluation and prediction of the ecological impact of antibiotics on the human microflora, as well as the use and the effects of drugs in human populations [9].

It is irrefutable that antibiotic use promotes resistance development. However, quantifying the specific contribution of antibiotic use to resistance poses some problems. Evidence is accumulating that social, economic and genetic factors also have impact on the establishment, maintenance and spread of resistance traits.

The likelihood of selecting resistance in the community depends on many factors. The key factors are shown in Table 1.

Section snippets

Total antimicrobial usage

Antibiotic usage and resistance rates vary from one country to another [2], [3], [4]. Cars et al. found that in 1997 the non-hospital usage of antibiotics between European Union countries varied more than fourfold (Table 2) [4].

Countries with the highest per capita antibiotic consumption have the highest resistance rates (Table 2). Table 2 indicates that in countries with the total outpatient antibiotic sales beyond 25 defined daily doses (DDD)/1000 inhabitants/day, the average resistance level

Class and group of antibiotics used

A study by Baquero et al. was one of the first to report a correlation between antibiotic use and bacterial resistance in the community [31]. The emergence of penicillin-resistant S. pneumoniae (PRSP) was linked to increased use of aminopenicillins in different geographical areas in Spain [31]. The lowest rates of PRSP occurred in countries with very low rates of β-lactam prescriptions [32] (Table 3).

In contrast, consumption is highest in Spain and France where penicillin resistance is also

Reversal of resistance

The first intervention to decrease bacterial resistance in the community occurred in Japan where decreased erythromycin consumption led to a decreased level of erythromycin-resistant S. pyogenes in the 1970s [68]. In Japan, 62% of S. pyogenes isolates were resistant to erythromycin in 1974, and macrolides accounted for 22% of all antibiotics used. By 1988, macrolides accounted for only 8% of antibiotic use and the proportion of S. pyogenes isolates resistant to erythromycin fell to 2%. Because

Dosage regimens

Using antibiotics with poor activity or administering them at an inappropriate dosing level, dosing frequency, or for a prolonged duration increases the opportunity for selection of resistant strains. Guillemot et al. found that children treated with low daily doses of an oral β-lactam had an increased risk of PRSP carriage compared with children who did not [73]. Prolonged treatment (>5 days) with a β-lactam was associated with increased risk of PRSP carriage. The study by Nasrin et al. also

Pharmacokinetics/pharmacodynamics

The pharmacokinetic and pharmacodynamic properties of antibacterial agents also influence the development of resistance both in the pathogen under therapy and in the normal flora in the gut and elsewhere. Pharmacokinetic/pharmacodynamic parameters have been correlated with the drug's ability to prevent the emergence of resistant organisms. Several animal and in vitro studies have suggested that peak/MIC values of 8–10 or higher, and 24-h AUC/MIC ratios of 100 or greater can significantly reduce

Cross-infections

Organisms can spread from person to person and between humans, animals, plants and other environments or by wide spread transfer of genetic material from the initial organisms to others [85]. Resistant strains vary in their propensity for spread according to the route of transmission of the species. Resistant strains of Salmonella typhi and Shigella dysenteriae, both widespread in many developing countries, pose little risk of widespread dissemination in developed countries provided that

Patient compliance and public behaviour

Compliance is influenced by a number of factors. Many patients stop taking their medication once their symptoms have resolved yet before bacterial eradication is complete. This can lead to reinfection and selection of resistant strains. In the second type of noncompliance the patient reduces the number of daily doses. Missing one dose leads inevitably to lower serum/tissue area under the curve, and to shorter time of antibiotic concentrations over the MIC during the corresponding period. Such

Conclusion

Antimicrobial agents were introduced into medical practice almost 60 years ago. Since then, the prevalence of antimicrobial resistance in community-acquired pathogens has increased worldwide. There is a complex relationship between the consumption of antimicrobial agents and the prevalence of drug resistance. Selective antibiotic pressure and spread of resistance both by spread of resistant bacteria, as well as by resistance genes transferred between bacteria are the major determinants of

Acknowledgments

I would like to thank Bojana Beovic and Marko Pokorn for his critical review and for his helping of the preparation of manuscript. I thank Andreja Sorman for her skilful technical assistance.

References (96)

  • F.C. Tenover et al.

    Reasons for the emergence of antibiotic resistance

    Am. J. Med. Sci.

    (1996)
  • R. Wise et al.

    Antimicrobal resistance is a major threat to public health

    Br. Med. J.

    (1998)
  • T.L. Sørensen et al.

    Control of antibiotic use in the community: the Danish experience

    Infect. Control Hosp. Epidemiol.

    (2000)
  • R.A. Bremon et al.

    Non-hospital consumption of antibiotics in Spain: 1987–1997

    J. Antimicrob. Chemother.

    (2000)
  • Standing Medical Advisory Committee: Subgroup on Medical Resistance. The Path of Least Resistance. Department of...
  • Ministry of Health, Ministry of Food, Agriculture and Fisheries. The Copenhagen Recommendations. Report from the...
  • GC Schito et al.

    The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project

    J. Antimicrob. Chemother.

    (2000)
  • D.F. Sahm et al.

    Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998

    J. Antimicrob. Chemother.

    (2000)
  • E. Perez-Trallero et al.

    Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998–1999) multicenter surveillance study in Spain

    Antimicrob. Agents Chemother.

    (2001)
  • Jacobs MR, Felmingham D, Appelbaum PC, Alexander Project group. The Alexander Project 1998; penicillin and macrolide...
  • Anon. Jarvanyugyi bakteriologiai halozat. 1998;...
  • Manninen R, Huovinen P, Nissinen A, The Finnish Study Group for Antimicrobial Resistance. Increasing antimicrobial...
  • M. Pihlajamäki et al.

    Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents

    Clin. Infect. Dis.

    (2001)
  • Cizman M, Pokorn M, Paragi M, Slovenian Meningitis Study Group. Antimicrobial resistance of invasive Streptococcus...
  • M. Lindbaek et al.

    Influence of prescription patterns in general practice on antimicrobial resistance in Norway

    Br. J. Gen. Pract.

    (1999)
  • S. Mölstad et al.

    Major change in the use of antibiotics following a national programme: Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance (STRAMA)

    Scand. J. Infect. Dis.

    (1999)
  • M. Arendrup et al.

    Prevalence of and detection of resistance to ampicillin and other β-lactam antibiotics in Haemophilus influenzae in Denmark

    Scand. J. Infect. Dis.

    (2001)
  • Milatovic D, Verhoef J, Fluit AC. Prevalence and genotypes of macrolide resistant Streptococcus pneumoniae and...
  • L.S. Stratchounski et al.

    Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia

    Pediatr. Infect. Dis. J.

    (2000)
  • Bruinsma N, Hutchinson JM, Giamarellou H et al. Importance of population density on the prevalence of antibiotic...
  • S.B. Levy

    Antibiotic resistance: consequences of inaction

    Clin. Infect. Dis.

    (2001)
  • Wise R, Andrews JM, Synercid resistance surveillance group. Local surveillance of antimicrobial resistance. Lancet...
  • D.M. Livermore et al.

    Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing

    J. Antimicrob. Chemother.

    (2000)
  • F. Baquero et al.

    A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe

    J. Antimicrob. Chemother.

    (1991)
  • F. Baquero

    Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study

    J. Antimicrob. Chemother.

    (1996)
  • S.L.A.M. Bronzwaer et al.

    A European study on the relationship between antimicrobial use and antimicrobial resistance

    Emerg. Infect. Dis.

    (2002)
  • C. Garcia-Rey et al.

    Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae

    J. Clin. Microbiol.

    (2002)
  • A. Nissienen et al.

    Development of β-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978–1993

    Clin. Infect. Dis.

    (1995)
  • D. Nasrin et al.

    Effect of β lactam antibiotic use in children on pneumococcal resistance to penicillin prospective cohort study

    Brit. Med. J.

    (2002)
  • F. Ghaffar et al.

    Effects of amoxicillin/clavulanate or azythromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media

    Clin. Infect. Dis.

    (2000)
  • E. Varon et al.

    Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in children with respiratory tract infection

    Clin. Infect. Dis.

    (2000)
  • M. Lipsitch

    Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae

    Clin. Infect. Dis.

    (2001)
  • V.A. Arason et al.

    Do antimicrobial increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

    Brit. Med. J.

    (1996)
  • E. Melander et al.

    Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children

    Eur. J. Clin. Microbiol. Infect. Dis.

    (1998)
  • H. Seppäla et al.

    Resistance to erythromycin in group A streptococci

    N. Engl. J. Med.

    (1992)
  • E. Perez-Trallero et al.

    Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain

    Eur. J. Clin. Microbiol. Infect. Dis.

    (1998)
  • M. Cizman et al.

    Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens

    Eur. J. Clin. Microbiol. Infect. Dis.

    (1999)
  • M. Cizman et al.

    The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens

    J. Antimicrob. Chemother.

    (2001)
  • Cited by (141)

    • In vitro and in vivo roles of cyanobacterial carbonic anhydrase as a biomarker for monitoring antibiotics

      2022, Journal of Hazardous Materials Letters
      Citation Excerpt :

      For example, the long-term release of low-dose antibiotics into the environment increases the resistance of pathogenic bacteria. In addition, antibiotic resistance genes can spread and evolve in the environment, posing potential threats to ecology and human health (Cizman, 2003; Korostynska et al., 2016). Although traditional monitoring methods for antibiotics, such as high-performance liquid chromatography and mass spectrometry, can qualitatively and quantitatively analyze antibiotics, these approaches have the disadvantages of requiring expensive instruments and being time-consuming.

    • Decentralized systems for the treatment of antimicrobial compounds released from hospital aquatic wastes

      2022, Science of the Total Environment
      Citation Excerpt :

      Antibiotics are often prescribed incorrectly in cases where the compounds produce no known health benefits, commonly misused in the treatment of cold and cough symptoms. Unnecessary usage of broad-spectrum antibiotics at incorrect dosages and durations as a result of poor patient adherence further contributes to excess consumption (Čižman, 2003). The total consumption of antiviral drugs in Africa is estimated to be 1085 tons/year and assuming a minimum excretion of 30%, 326 tons of antivirals were excreted into the environment.

    • Introduction of the antibacterial drugs norfloxacin and Ciprofloxacin into a polyoxometalate structure: Synthesis, characterization, and antibacterial activity

      2020, Journal of Molecular Structure
      Citation Excerpt :

      Some structural investigations of metal compounds (including Co(II), Ni(II), and Cu(II)) of quinolones have been reported previously [26–29]. The biological properties of quinolone metal complexes that have been examined are mainly their antibacterial activity against microorganisms, their interaction with DNA and, in some cases, their potential antitumor activity [30–33]. Recently, the crystal structures of cobalt complexes of gatifloxacin [17], enrofloxacin [34], pipemidic acid [35], and norfloxacin have also been reported [36].

    View all citing articles on Scopus
    View full text